Chemoprophylaxis refers to the use of chemical agents, such as drugs or medications, to prevent the development or spread of infectious diseases. This proactive approach is often employed in situations where the risk of infection is high, such as during outbreaks or in specific populations with increased vulnerability. Common examples of chemoprophylaxis include the use of antibiotics to prevent bacterial infections, antimalarial drugs for travelers visiting regions with malaria, and antiviral medications for preventing certain viral infections. The choice of the chemoprophylactic agent depends on the specific pathogen and the characteristics of the population at risk. Chemoprophylaxis is widely utilized in public health strategies, such as in the prevention of sexually transmitted infections, tuberculosis, and certain parasitic diseases. The effectiveness of chemoprophylaxis relies on factors like the timing of administration, compliance with the prescribed regimen, and the emergence of drug resistance. While chemoprophylaxis is a valuable tool in disease prevention, its use requires careful consideration of factors such as potential side effects, the development of resistance, and the overall impact on public health. Proper education, monitoring, and adherence to guidelines are crucial for the success of chemoprophylaxis programs.
Title : A promising novel approach to DNA vaccines
Khursheed Nadeem Anwer, IMUNON, United States
Title : Nanoscopic SubATVax™ adjuvanted vaccines against influenza A types H3N2, H1N1 and influenza type B for subcutaneous administration
David Craig Wright, D4 Labs, LLC, United States
Title : The importance of post-marketing surveillance and real-world data for a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Commensal bacteria drive B-cell lymphomagenesis in the setting of innate immunodeficiency
Ping Xie, Rutgers University, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Evaluating the immunogenic impact of process impurities in mRNA vaccine production: Establishing integrated control strategies and specifications
Jesse Kuiper, Merck Research Laboratories, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Advances in vaccines: Revolutionizing disease prevention
Delia Teresa Sponza, Dokuz Eylul University, Turkey